Volume No. :   8

Issue No. :  1

Year :  2018

ISSN Print :  2231-5640

ISSN Online :  2231-5659


Allready Registrered
Click to Login

Probenecid Act as an Uricosuric agent: A Review

Address:   Mr. Mayur S. Jain1*, Dr. Shashikant D. Barhate2, Mr. Bhushan P. Gayakwad3
Shree Sureshadada Jain Institutes of Pharmaceutical Education and Research, Jammer, Maharashtra (India).
*Corresponding Author
DOI No: 10.5958/2231-5659.2018.00010.3

Probenecid is s prototypical uricosuric agent which is predominantly used to inhibit the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. Probenecid, also sold under the brand name Probalan, is a medication that increases uric acid excretion in the urine. It is primarily used in treatment of gout and hyperuricemia. Probenecid was developed as an alternative to caronamide to competitively inhibit renal excretion of some drugs, thereby increasing their plasma concentration and prolonging their effects.
Probenecid; Uricosuric agent; Gout
Mr. Mayur S. Jain, Dr. Shashikant D. Barhate, Mr. Bhushan P. Gayakwad. Probenecid Act as an Uricosuric agent: A Review. Asian J. Res. Pharm. Sci. 2018; 8(1):45-47.
[View HTML]      [View PDF]

Visitor's No. :   211893